Graft-Versus-Host Disease

Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.- Xenogeneic Animal Models of Graft-Versus-Host Disease.- Utilisation of Clinical Data and Evaluation of Biomarkers in the Investigation of Graft-Versus-Host Disease Outcomes.- Endothelial Activation and Stress Index (EASIX) – A Prognostic Marker for Mortality After Acute Graft-Versus-Host-Disease and Endothelial Complications.- Assessment of Survivorship in Allogeneic Haematopoietic Stem Cell Transplantation.- Allogeneic Mouse Models of Graft-Versus-Host Disease.- Transplantation and Monitoring of a Murine Minor Histocompatibility Antigen-Mismatched Model of Graft-versus-Host Disease.- A Clinically Relevant Mouse Model of Reduced Intensity Conditioning for Allogeneic HLA-identical Haematopoietic Stem Cell Transplantation.- Humanised Mouse Model of Graft-Versus-Host Disease Utilising Non-irradiated NOD-scid-IL-2Rγnull Mice.- Canine Haematopoietic Cell Transplantation for Graft-Versus-Host Disease.- Flow Cytometry Analysis of Graft Conditioning on the T cell Response in Graft-versus-host Disease Following Murine Allogeneic Transplantation.- Mass Cytometry Immunophenotyping of Graft Conditioned Cells Following Major Histocompatibility Complex Mismatched Murine Allograft.- Mixed Leukocyte Reaction Using Human Blood Monocyte-Derived Dendritic Cells and Memory CD4+ T Cells.- Mixed Leukocyte Reaction Using Human Plasmacytoid Dendritic Cells and CD4+ T Cells.-Protocols for Studying Graft-Versus-Leukaemia Immunity in Mice.- Use of Human Chronic Myeloid Leukaemia Cells to Study Graft-versus-Leukaemia Immunity in a Xenogeneic Mouse Model of Graft-versus-Host Disease.